Topic: GlaxoSmithKline plc
British pharmaceutical giant GlaxoSmithKline withheld from US drug safety regulators information about the possible dangers of top-selling diabetes drug Avandia, a report in the US press said Tuesday.The allegation was made in the Wall Street Journal on the day that Food and ...
7/13/2010 Print E-mail The pharmacy company that makes Avandia knew more than a decade ago that the blockbuster diabetes drug caused an increased risk of heart problems but covered up the information, according to a report published Tuesday in The New York ...
WASHINGTON (Reuters) - A heated three-year safety debate about a GlaxoSmithKline Plc diabetes pill reaches a climax this week as opponents and backers face off at a U.S. meeting that will help decide the drug's fate.A panel of scientific experts meets later ...
One step ahead of a planned government review of the safety of Avandia, new doubts surfaced Friday on a key trial that helped keep the blockbuster diabetes drug on the market.. A medical reviewer for the U.S. Food and Drug Administration posted ...
European Medicines Agency to review safety of GlaxoSmithKline's diabetes drug AvandiaThe European Medicines Agency says it will review the safety of the diabetes drug Avandia following research suggesting it is linked to a higher risk of heart problems, strokes and deaths in ...
LONDON (Reuters) - European regulators are launching a new probe into the safety of GlaxoSmithKline Plc's diabetes pill Avandia, adding to pressure on a medicine that already faces a grilling from U.S. experts next week.The European Medicines Agency (EMA) said on Friday ...
WASHINGTON (Reuters) - Low doses of GlaxoSmithKline's diabetes drug Avandia combined with metformin can prevent diabetes without causing the most common side-effects, Canadian doctors reported on Wednesday.Taking half a dose of Glaxo's combination pill reduced by two-thirds the risk that patients would ...
WASHINGTON (Reuters) - An major trial of Avandia puts patients at risk and should be stopped, a U.S. advocacy group said on Tuesday, calling on regulators to immediately halt the global study of the controversial GlaxoSmithKline Plc diabetes drug.The U.S. Food and ...
The FDA is considering cutting short a trial comparing the safety of two diabetes drugs - GlaxoSmithKline's Avandia and Takeda's Actos, the WSJ reports. Given that Avandia has been linked since 2007 to an increased risk of heart attacks, some scientists have ...
Glaxo fires back against Senate report, says it disclosed safety risks to FDA in 2005 GlaxoSmithKline said Wednesday a Senate report criticizing its handling of heart risks with its diabetes drug Avandia "The Senate report, issued over the weekend, charged that Glaxo ...
Photo Gallery
From Around the Web
Video Gallery
-
News Update: New Study Shows GlaxoSmithKline ...
A study in the Journal of the American Medical Association ...2010-06-28 -
GlaxoSmithKline up 1%; Pronova Biopharma Settles ...
GlaxoSmithKline plc (GSK) shares are up 0.89% to $38 ...2011-03-30 -
GlaxoSmithKline Plc (GSK)
Everyone is looking for a nice save haven in these ...2008-02-13
